Literature DB >> 31727209

Tourette disorder and other tic disorders.

Wissam Deeb1, Irene A Malaty1, Carol A Mathews2.   

Abstract

A combination of motor and phonic tics is the hallmark of Tourette syndrome (TS). This complex neuropsychiatric disorder is often associated with psychiatric comorbidities such as attention-deficit hyperactivity disorder and obsessive-compulsive disorder. The first step in management is to establish the diagnosis of TS, avoiding potential diagnostic confounders (such as compulsions, stereotypies, or habits). Once a diagnosis of TS is made, a discussion with the patient and family about the level of impairment and presence or absence of comorbidities will guide the decision and choice of treatment. Not every patient with TS will need active treatment. When needed, active treatment falls into one of the following three categories: behavioral, pharmacologic, and nonpharmacologic. This chapter summarizes and reviews the evidence base supporting these treatments. It also discusses the evidence base and approach to the treatment of common psychiatric comorbidities. A treatment algorithm based on published data and expert consensus is proposed.
Copyright © 2019 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Attention-deficit hyperactivity disorder; Comprehensive behavioral intervention for tics; Deep brain stimulation; Obsessive–compulsive disorder; Pharmacologic treatment; Tics; Tourette syndrome; Treatment-resistant

Mesh:

Substances:

Year:  2019        PMID: 31727209     DOI: 10.1016/B978-0-444-64012-3.00008-3

Source DB:  PubMed          Journal:  Handb Clin Neurol        ISSN: 0072-9752


  7 in total

Review 1.  The prefrontal cortex and OCD.

Authors:  Susanne E Ahmari; Scott L Rauch
Journal:  Neuropsychopharmacology       Date:  2021-08-16       Impact factor: 7.853

Review 2.  Randomized controlled trials on the use of cannabis-based medicines in movement disorders: a systematic review.

Authors:  P Oikonomou; W H Jost
Journal:  J Neural Transm (Vienna)       Date:  2022-07-20       Impact factor: 3.850

3.  Tic Disorders, Anti-Tic Medications, and Risk of Atopy.

Authors:  Mathew Hakimi; Sandra Skinner; Carine W Maurer
Journal:  Mov Disord Clin Pract       Date:  2022-07-12

4.  Correlation between Serum Levels of Vitamin A and Vitamin D with Disease Severity in Tic Disorder Children.

Authors:  Helin Wang; Yali Yang; Dandan Zhou; Chengjie Bai; Minqiang Shi
Journal:  Evid Based Complement Alternat Med       Date:  2022-05-31       Impact factor: 2.650

Review 5.  European clinical guidelines for Tourette syndrome and other tic disorders-version 2.0. Part III: pharmacological treatment.

Authors:  Veit Roessner; Heike Eichele; Jeremy S Stern; Liselotte Skov; Renata Rizzo; Nanette Mol Debes; Péter Nagy; Andrea E Cavanna; Cristiano Termine; Christos Ganos; Alexander Münchau; Natalia Szejko; Danielle Cath; Kirsten R Müller-Vahl; Cara Verdellen; Andreas Hartmann; Aribert Rothenberger; Pieter J Hoekstra; Kerstin J Plessen
Journal:  Eur Child Adolesc Psychiatry       Date:  2021-11-10       Impact factor: 4.785

6.  Striatal Syntaxin 1A Is Associated with Development of Tourette Syndrome in an Iminodipropionitrile-Induced Animal Model.

Authors:  Liu Yang; Xueming Wang; Xiumei Liu; Xin Chen
Journal:  Dis Markers       Date:  2022-09-14       Impact factor: 3.464

Review 7.  Tourette Syndrome Treatment Updates: a Review and Discussion of the Current and Upcoming Literature.

Authors:  Jessica Frey; Irene A Malaty
Journal:  Curr Neurol Neurosci Rep       Date:  2022-02-02       Impact factor: 6.030

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.